{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:00:26Z","timestamp":1783544426704,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obesity or underweight can complicate and aggravate symptoms and progression of right heart failure in patients with pulmonary arterial hypertension (PAH). This study investigates the influence of different body mass index (BMI) categories on right heart function and outcome in PAH patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study with survival follow-up (mean follow-up 3.1\u2009\u00b1\u20092.6\u00a0years, median 2.7\u00a0years), clinical measures such as WHO-functional class and invasively measured hemodynamic parameters at initial diagnosis of PAH were compared between different BMI groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 2055 data sets, 755 patients with PAH (62.5% female) were eligible for the study (65\u2009\u00b1\u200915\u00a0years, 44.9% idiopathic PAH, 64.8% WHO functional class III or IV). Out of them 15 patients (1.99%) were underweight (BMI\u2009&lt;\u200918\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ), 248 (32.85%) patients had a normal weight (BMI 18.5\u201325\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ), 256 (33.91%) were overweight (BMI\u2009&gt;\u200925 to 30\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ) and 236 patients (31.26%) were classified as obese (BMI\u2009&gt;\u200930\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ). Worst survival was denoted for patients with BMI\u2009&lt;\u200918.5\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , best survival for BMI\u2009&gt;\u200925 to 30\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . Cardiac output (CO) significantly differed between BMI groups (p\u2009&lt;\u20090.0001, R\u2009=\u20090.268) and sex. In multivariable age-adjusted survival analysis, BMI-status, sex and right ventricular function were identified as independent predictors of survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is the first study to assess RV function with regard to BMI status and survival in PAH. The study underlines the importance of the parameter body weight in the clinical management of PAH patients. It provides important insights in the relations of BMI and CO and documented significant gender differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-025-02682-9","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T03:26:43Z","timestamp":1750735603000},"page":"459-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Right ventricular function in pulmonary hypertension and obesity: a cross-sectional cohort study with survival follow-up"],"prefix":"10.1007","volume":"115","author":[{"given":"B.","family":"Egenlauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Xanthouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Harutyunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Eichstaedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Erbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gr\u00fcnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"issue":"38","key":"2682_CR1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M et al (2022) 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43(38):3618\u20133731","journal-title":"Eur Heart J"},{"issue":"10","key":"2682_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S2213-2600(22)00097-2","volume":"10","author":"MM Hoeper","year":"2022","unstructured":"Hoeper MM et al (2022) Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis. Lancet Respir Med 10(10):937\u2013948","journal-title":"Lancet Respir Med"},{"issue":"12","key":"2682_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11906-018-0899-2","volume":"20","author":"K Ayinapudi","year":"2018","unstructured":"Ayinapudi K et al (2018) Obesity and pulmonary hypertension. Curr Hypertens Rep 20(12):99","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"2682_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1378\/chest.11-0172","volume":"141","author":"H Chahal","year":"2012","unstructured":"Chahal H et al (2012) Obesity and right ventricular structure and function: the MESA-Right Ventricle Study. Chest 141(2):388\u2013395","journal-title":"Chest"},{"issue":"6","key":"2682_CR5","doi-asserted-by":"publisher","first-page":"1801524","DOI":"10.1183\/13993003.01524-2018","volume":"53","author":"KM Mair","year":"2019","unstructured":"Mair KM et al (2019) Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension. Eur Respir J 53(6):1801524","journal-title":"Eur Respir J"},{"issue":"2","key":"2682_CR6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1378\/chest.09-1140","volume":"137","author":"DB Badesch","year":"2010","unstructured":"Badesch DB et al (2010) Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 137(2):376\u2013387","journal-title":"Chest"},{"issue":"7","key":"2682_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41569-023-00847-5","volume":"20","author":"PL Valenzuela","year":"2023","unstructured":"Valenzuela PL et al (2023) Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol 20(7):475\u2013494","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"2682_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014195","volume":"9","author":"RC Frank","year":"2020","unstructured":"Frank RC et al (2020) Obesity is associated with pulmonary hypertension and modifies outcomes. J Am Heart Assoc 9(5):e014195","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"2682_CR9","first-page":"419","volume":"10","author":"R Reddy","year":"2023","unstructured":"Reddy R et al (2023) Effect of obesity on mortality in pulmonary hypertension\u2014a systematic review and meta-analysis. J Cardiovasc Dev Dis 10(10):419","journal-title":"J Cardiovasc Dev Dis"},{"issue":"4","key":"2682_CR10","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.chest.2018.05.006","volume":"154","author":"J Weatherald","year":"2018","unstructured":"Weatherald J et al (2018) Association between BMI and obesity with survival in pulmonary arterial hypertension. Chest 154(4):872\u2013881","journal-title":"Chest"},{"key":"2682_CR11","unstructured":"WHO Consultation on Obesity (1999) and World Health Organization, Obesity: preventing and managing the global epidemic. Report of a WHO consultation. 2000, World Health Organization, Geneva, p 252"},{"issue":"6","key":"2682_CR12","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1183\/09031936.00050713","volume":"42","author":"G Kovacs","year":"2013","unstructured":"Kovacs G et al (2013) Zero reference level for right heart catheterisation. Eur Respir J 42(6):1586\u20131594","journal-title":"Eur Respir J"},{"key":"2682_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/978-1-4612-3068-7","volume-title":"Diagnosis of heart disease","author":"NO Fowler","year":"1991","unstructured":"Fowler NO (1991) Diagnosis of heart disease, vol 1. Springer, New York, p 429"},{"key":"2682_CR14","unstructured":"Hoeper MM et al (2022) Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry. Eur Respir J 59(6)"},{"issue":"6","key":"2682_CR15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1161\/01.CIR.103.6.820","volume":"103","author":"T Collis","year":"2001","unstructured":"Collis T et al (2001) Relations of stroke volume and cardiac output to body composition: the strong heart study. Circulation 103(6):820\u2013825","journal-title":"Circulation"},{"issue":"4","key":"2682_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s13679-016-0235-6","volume":"5","author":"MA Alpert","year":"2016","unstructured":"Alpert MA, Omran J, Bostick BP (2016) Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function. Curr Obes Rep 5(4):424\u2013434","journal-title":"Curr Obes Rep"},{"issue":"4","key":"2682_CR17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/01.CCM.0000208358.27005.F4","volume":"34","author":"HT Stelfox","year":"2006","unstructured":"Stelfox HT et al (2006) Hemodynamic monitoring in obese patients: the impact of body mass index on cardiac output and stroke volume. Crit Care Med 34(4):1243\u20131246","journal-title":"Crit Care Med"},{"issue":"1","key":"2682_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.rmed.2012.10.019","volume":"107","author":"B Zafrir","year":"2013","unstructured":"Zafrir B et al (2013) The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the \u201cobesity paradox.\u201d Respir Med 107(1):139\u2013146","journal-title":"Respir Med"},{"issue":"4","key":"2682_CR19","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1378\/chest.15-0300","volume":"148","author":"HW Farber","year":"2015","unstructured":"Farber HW et al (2015) Five-Year outcomes of patients enrolled in the REVEAL Registry. Chest 148(4):1043\u20131054","journal-title":"Chest"},{"issue":"8","key":"2682_CR20","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/ijo.2017.45","volume":"41","author":"S Mazimba","year":"2017","unstructured":"Mazimba S et al (2017) Obesity paradox in group 1 pulmonary hypertension: analysis of the NIH-Pulmonary Hypertension registry. Int J Obes (Lond) 41(8):1164\u20131168","journal-title":"Int J Obes (Lond)"},{"issue":"9","key":"2682_CR21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.healun.2011.03.011","volume":"30","author":"RL Benza","year":"2011","unstructured":"Benza RL et al (2011) Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials. J Heart Lung Transpl 30(9):982\u2013989","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"2682_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s13679-020-00394-x","volume":"9","author":"I Karampela","year":"2020","unstructured":"Karampela I et al (2020) Is there an obesity paradox in critical illness? Epidemiologic and metabolic considerations. Curr Obes Rep 9(3):231\u2013244","journal-title":"Curr Obes Rep"},{"issue":"2","key":"2682_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/1568026611313020002","volume":"13","author":"V Panagopoulou","year":"2013","unstructured":"Panagopoulou V et al (2013) NTproBNP: an important biomarker in cardiac diseases. Curr Top Med Chem 13(2):82\u201394","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"2682_CR24","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/ehf2.13386","volume":"8","author":"A Schmeisser","year":"2021","unstructured":"Schmeisser A et al (2021) Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction. ESC Heart Fail 8(4):2968\u20132981","journal-title":"ESC Heart Fail"},{"issue":"10","key":"2682_CR25","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.amjcard.2015.02.024","volume":"115","author":"A Sharma","year":"2015","unstructured":"Sharma A et al (2015) Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol 115(10):1428\u20131434","journal-title":"Am J Cardiol"},{"issue":"3","key":"2682_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/clc.23970","volume":"46","author":"R Chen","year":"2023","unstructured":"Chen R et al (2023) Prevalence of sarcopenia and its association with clinical outcomes in heart failure: an updated meta-analysis and systematic review. Clin Cardiol 46(3):260\u2013268","journal-title":"Clin Cardiol"},{"issue":"1","key":"2682_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.hfc.2022.09.001","volume":"19","author":"AM Marra","year":"2023","unstructured":"Marra AM et al (2023) Impact of hormonal-anabolic deficiencies in idiopathic pulmonary arterial hypertension. Heart Fail Clin 19(1):115\u2013123","journal-title":"Heart Fail Clin"},{"issue":"2","key":"2682_CR28","first-page":"243","volume":"38","author":"SJ Cassady","year":"2020","unstructured":"Cassady SJ, Ramani GV (2020) Right heart failure in pulmonary hypertension. Cardiol Clin 38(2):243\u2013255","journal-title":"Cardiol Clin"},{"issue":"3","key":"2682_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.12258","volume":"13","author":"HW Farber","year":"2023","unstructured":"Farber HW et al (2023) Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real-world patient data repository. Pulm Circ 13(3):e12258","journal-title":"Pulm Circ"},{"issue":"6","key":"2682_CR30","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ijo.2008.11","volume":"32","author":"A Romero-Corral","year":"2008","unstructured":"Romero-Corral A et al (2008) Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) 32(6):959\u2013966","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"2682_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.numecd.2014.10.005","volume":"25","author":"AM Marra","year":"2015","unstructured":"Marra AM et al (2015) Pulmonary arterial hypertension-related myopathy: an overview of current data and future perspectives. Nutr Metab Cardiovasc Dis 25(2):131\u2013139","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"23","key":"2682_CR32","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1093\/eurheartj\/ehaa696","volume":"42","author":"E Gr\u00fcnig","year":"2021","unstructured":"Gr\u00fcnig E et al (2021) Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. Eur Heart J 42(23):2284\u20132295","journal-title":"Eur Heart J"},{"key":"2682_CR33","unstructured":"Gr\u00fcnig E et al (2019) ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension. Eur Respir J 53(2)"},{"issue":"1","key":"2682_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/eurheartj\/ehv337","volume":"37","author":"N Ehlken","year":"2016","unstructured":"Ehlken N et al (2016) Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. Eur Heart J 37(1):35\u201344","journal-title":"Eur Heart J"},{"issue":"6","key":"2682_CR35","doi-asserted-by":"publisher","first-page":"875","DOI":"10.5811\/westjem.2019.9.43732","volume":"20","author":"B Long","year":"2019","unstructured":"Long B, Koyfman A, Gottlieb M (2019) Diagnosis of acute heart failure in the emergency department: an evidence-based review. West J Emerg Med 20(6):875\u2013884","journal-title":"West J Emerg Med"},{"issue":"3","key":"2682_CR36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.14740\/jocmr2890w","volume":"9","author":"T Komaki","year":"2017","unstructured":"Komaki T et al (2017) The change in body weight during hospitalization predicts mortality in patients with acute decompensated heart failure. J Clin Med Res 9(3):200\u2013206","journal-title":"J Clin Med Res"},{"issue":"12","key":"2682_CR37","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1111\/echo.13712","volume":"34","author":"DM Patton","year":"2017","unstructured":"Patton DM et al (2017) A quality control exercise in the echo laboratory: reduction in inter-observer variability in the interpretation of pulmonary hypertension. Echocardiography 34(12):1882\u20131887","journal-title":"Echocardiography"},{"issue":"7","key":"2682_CR38","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S0300-8932(10)70183-4","volume":"63","author":"M Pinedo","year":"2010","unstructured":"Pinedo M et al (2010) Inter- and intra-observer variability in the echocardiographic evaluation of right ventricular function. Rev Esp Cardiol 63(7):802\u2013809","journal-title":"Rev Esp Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02682-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02682-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02682-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:58:30Z","timestamp":1770796710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02682-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2682"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02682-9","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BE: received travel fees, consulting fees, speaking fees, and\/or honoraria from Janssen, MSD, Bayer and OMT, outside the submitted work. MB, VS, AMM, CAE, CE, RS, FL, NB: nothing to declare. PX: has received personal fees from MSD and OMT outside the submitted work. SH: received honoraria for lectures, consultancy, or both from Actelion, AOP, Bayer\/MSD, GSK, Novartis, OMT, Pfizer, and United Therapeutics outside the submitted work. EG: has received grants and personal fees from Actelion, Bayer AG, and MSD; grants from GSK, Novartis, and United Therapeutics and personal fees from SCOPE, OrPha Swiss GmbH, and Zurich Heart House, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}